New research by the Daffodil Centre, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australia almost quadrupled between 1983 and 2017, foreshadowing a growing preventable cancer crisis unless urgent steps are taken to reverse Australias obesity epidemic.
The Daffodil Centre analysed 35-year rates of 10 cancer types* in Australia, which according to World Health Organisation and World Cancer Research Fund findings, are associated with obesity.
Senior Research Fellow and lead author of the research, Dr Eleonora Feletto, said the study found for cancers with an association to overweight and obesity, incidence was almost three times higher in young people, compared to those born in the late 1940s. For cancers without a clear association to overweight and obesity, we didnt see the same rise, highlighting the growing concern for obesity as a public health epidemic.
Compared with other cancers, those strongly associated with obesity increased in incidence between 1983 and 2017 at an alarming rate.
Chair of Cancer Councils Nutrition, Alcohol and Physical Activity Committee, Clare Hughes, said Australia is facing a large public health issue, we are a wealthy country thats proud of its health system, yet weve seen obesity rates continue to increase over decades.
The research also showed a sharp increase in obesity-related cancers for people born after 1960, a time where rates of obesity in Australia began to rise significantly.
Recent decades have seen changes in food supply, eating patterns, a rise in convenience and ultra-processed foods, overconsumption and inactive lifestyles all of which create an environment that leads to increased body mass and poor health. With our research showing that the results of the obesity epidemic are leading to escalating preventable cancer incidence, governments need to take strong action to support improved nutrition and physical activity. Hughes said.
Common cancers with an association with obesity, such as bowel cancer, saw up to three-fold increases in incidence for younger people, while less common cancers associated with obesity, such as liver, kidney, uterine, thyroid and pancreatic cancers, saw similar, if not higher, increases in incidence.
In total, more than 1 million cases of cancer types that have an established association with obesity were diagnosed over the 35-year period, Dr Feletto said. The extent to which obesity directly causes these cancers varies. A pattern has emerged across all 10, showing that cancers related to obesity are increasing in incidence at a faster rate than those that are not obesity related.
Halting and reversing the rise in obesity rates by 2030 is a target of both the ³Ô¹ÏÍøÕ¾ Preventive Health Strategy and the ³Ô¹ÏÍøÕ¾ Obesity Strategy. Cancer Council is calling on all governments to implement the recommendations of the ³Ô¹ÏÍøÕ¾ Obesity Strategy to raise awareness of the health consequences of obesity and introduce policies to address the environmental factors that contribute to excess weight gain.
For all media enquiries and interview opportunities, please contact Cancer Council:
- Annabel Jones, Cancer Council NSW [email protected] 02 9334 1872
- Cancer Council Australia Media Team [email protected] 02 8256 4109
About the Daffodil Centre
The Daffodil Centre is a joint venture between the University of Sydney and Cancer Council NSW. As a leading research centre on cancer control and policy, The Daffodil Centre provides timely and relevant evidence to national and international policy-makers to inform best-practice decision-making in cancer control. daffodilcentre.org
Eleonora Feletto, Ankur Kohar, David Mizrahi, Paul Grogan, Julia Steinberg, Clare Hughes, Wendy L. Watson, Karen Canfell, Xue Qin Yu, An ecological study of obesity-related cancer incidence trends in Australia from 1983 to 2017, The Lancet Regional Health – Western Pacific, Volume 29, 2022, 100575, ISSN 2666-6065, [].
Notes : *Cancers analysed were those of the bowel, liver, gallbladder, pancreas, breast (postmenopausal women), uterus, ovary, kidney and thyroid, and multiple myeloma.
